ClinicalTrials.Veeva

Menu

Physical Activity Level in Psychosis Patients

B

Bandırma Onyedi Eylül University

Status

Completed

Conditions

Psychosis

Study type

Observational

Funder types

Other

Identifiers

NCT06408740
2023-129

Details and patient eligibility

About

The aim of this study was to examine the effect of physical activity level on social participation, functioning and quality of life in patients with psychosis.

Full description

Positive and negative symptoms of schizophrenia will be assessed using the Positive and Negative Syndrome Scale, depression will be assessed using the Calgary Depression in Schizophrenia Scale, medication side effects will be assessed using the Glasgow Antipsychotic Side Effect Rating Scale, physical activity level will be assessed using the International Physical Activity Form, social participation will be assessed using the Social Participation Questionnaire, functioning will be assessed using the Brief Functioning Assessment Scale and quality of life will be assessed using the Nottingham Health Profile. The assessments are planned to last 30 minutes for each participant. Participants will be assessed only once and will not be reassessed.

Enrollment

157 patients

Sex

Female

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with schizophrenia and other psychotic disorders according to DSM-V criteria (brief psychosis disorder, schizophreniform disorder, schizoaffective disorder, other disorder with psychosis within the scope of another defined schizophrenia and other disorders with psychosis, other disorders with psychosis within the scope of undefined schizophrenia and other disorders with psychosis), who have had their first episode, who are receiving outpatient treatment
  • Whose duration of illness is longer than 2 years
  • Being between the ages of 18-65
  • Being literate

Exclusion criteria

  • The participant is in a period of active illness that makes it difficult to conduct research (Positive and Negative Syndrome Scale>70 scale points, Calgary Depression in Schizophrenia Scale score >11 scale points)
  • Comorbid psychiatric illness
  • The patient has an acute or chronic physical illness that impairs the general medical condition and a disease that will affect cognitive functions (neurological, neoplastic, endocrine and immune disorders, infection, epilepsy or any neurological disease, etc.).
  • The patient has a physical illness (loss of limbs, paralysis, etc.) that requires additional care and causes significant disability
  • Alcohol and substance use disorder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems